Tissue-nonspecific Alkaline Phosphatase [EPC]

4516 reported adverse events

Drugs of this class: ASFOTASE ALFA

These side effects are most commonly reported by patients taking drugs of the Tissue-nonspecific Alkaline Phosphatase [EPC] class:

# Side effect Count
0 INJECTION SITE PAIN 465
1 INJECTION SITE ERYTHEMA 391
2 INJECTION SITE REACTION 363
3 PAIN 315
4 FATIGUE 311
5 BLOOD ALKALINE PHOSPHATASE INCREASED 263
6 PAIN IN EXTREMITY 224
7 ARTHRALGIA 221
8 INJECTION SITE BRUISING 197
9 INJECTION SITE SWELLING 176
See all common reactions for Tissue-nonspecific Alkaline Phosphatase [EPC]

Drugs of the Tissue-nonspecific Alkaline Phosphatase [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ADMINISTRATION SITE DYSAESTHESIA 1 1.0000
1 VITAMIN B6 ABNORMAL 10 0.5263
2 VITAMIN B6 DECREASED 36 0.4186
3 PSEUDOFRACTURE 2 0.4000
4 ADENOSINE DEAMINASE ABNORMAL 1 0.2500
5 INJECTION SITE DEFORMATION 9 0.2432
6 VITAMIN B6 INCREASED 17 0.2208
7 BEHAVIOUR DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.1429
8 HYPOPHOSPHATASIA 5 0.1429
9 ADENOSINE DEAMINASE INCREASED 1 0.1111
See all enriched reactions for Tissue-nonspecific Alkaline Phosphatase [EPC]